Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

October 7, 2021

Study Completion Date

October 7, 2021

Conditions

Solid Tumor

Interventions

DRUG

Docetaxel

Docetaxel in NanoZolid formulation, for intratumoural injection

Trial Locations (4)

Herlev Hospital, Copenhagen

Lithuanian University of Health Sciences, Kaunas

National Cancer Institute, Vilnius

Karolinska University Hospital, Stockholm